Literature DB >> 23161122

Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.

L Brualla1, J Sempau, F J Zaragoza, A Wittig, W Sauerwein.   

Abstract

BACKGROUND: Irradiation of intraocular tumors requires dedicated techniques, such as brachytherapy with (106)Ru plaques. The currently available treatment planning system relies on the assumption that the eye is a homogeneous water sphere and on simplified radiation transport physics. However, accurate dose distributions and their assessment demand better models for both the eye and the physics.
METHODS: The Monte Carlo code PENELOPE, conveniently adapted to simulate the beta decay of (106)Ru over (106)Rh into (106)Pd, was used to simulate radiation transport based on a computerized tomography scan of a patient's eye. A detailed geometrical description of two plaques (models CCA and CCB) from the manufacturer BEBIG was embedded in the computerized tomography scan.
RESULTS: The simulations were firstly validated by comparison with experimental results in a water phantom. Dose maps were computed for three plaque locations on the eyeball. From these maps, isodose curves and cumulative dose-volume histograms in the eye and for the structures at risk were assessed. For example, it was observed that a 4-mm anterior displacement with respect to a posterior placement of a CCA plaque for treating a posterior tumor would reduce from 40 to 0% the volume of the optic disc receiving more than 80 Gy. Such a small difference in anatomical position leads to a change in the dose that is crucial for side effects, especially with respect to visual acuity. The radiation oncologist has to bring these large changes in absorbed dose in the structures at risk to the attention of the surgeon, especially when the plaque has to be positioned close to relevant tissues.
CONCLUSION: The detailed geometry of an eye plaque in computerized and segmented tomography of a realistic patient phantom was simulated accurately. Dose-volume histograms for relevant anatomical structures of the eye and the orbit were obtained with unprecedented accuracy. This represents an important step toward an optimized brachytherapy treatment of ocular tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161122     DOI: 10.1007/s00066-012-0245-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  26 in total

1.  Calculation of beta-ray dose distributions from ophthalmic applicators and comparison with measurements in a model eye.

Authors:  W G Cross; J Hokkanen; H Järvinen; F Mourtada; P Sipilä; C G Soares; S Vynckier
Journal:  Med Phys       Date:  2001-07       Impact factor: 4.071

2.  A PENELOPE-based system for the automated Monte Carlo simulation of clinacs and voxelized geometries-application to far-from-axis fields.

Authors:  Josep Sempau; Andreu Badal; Lorenzo Brualla
Journal:  Med Phys       Date:  2011-11       Impact factor: 4.071

3.  Clinical quality assurance for 106Ru ophthalmic applicators.

Authors:  Theodor W Kaulich; Jens Zurheide; Thomas Haug; Fridtjof Nüsslin; Michael Bamberg
Journal:  Radiother Oncol       Date:  2005-07       Impact factor: 6.280

Review 4.  Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning.

Authors:  Indrin J Chetty; Bruce Curran; Joanna E Cygler; John J DeMarco; Gary Ezzell; Bruce A Faddegon; Iwan Kawrakow; Paul J Keall; Helen Liu; C M Charlie Ma; D W O Rogers; Jan Seuntjens; Daryoush Sheikh-Bagheri; Jeffrey V Siebers
Journal:  Med Phys       Date:  2007-12       Impact factor: 4.071

5.  Dosimetry and design of radioactive eye plaques.

Authors:  D Flühs; M Bambynek; M Heintz; F Indenkämpen; H Kolanoski; D Wegener; W Sauerwein; U Quast
Journal:  Front Radiat Ther Oncol       Date:  1997

Review 6.  Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.

Authors:  P Lommatzsch
Journal:  Surv Ophthalmol       Date:  1974 Sep-Oct       Impact factor: 6.048

7.  Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque.

Authors:  Andreas O Schueler; Dirk Flühs; Gerasimos Anastassiou; Christine Jurklies; Wolfgang Sauerwein; Norbert Bornfeld
Journal:  Ophthalmic Res       Date:  2005-09-13       Impact factor: 2.892

8.  Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience.

Authors:  P K Lommatzsch
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

9.  Monte Carlo based water/medium stopping-power ratios for various ICRP and ICRU tissues.

Authors:  José M Fernández-Varea; Pablo Carrasco; Vanessa Panettieri; Lorenzo Brualla
Journal:  Phys Med Biol       Date:  2007-10-16       Impact factor: 3.609

10.  Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106.

Authors:  Georg Mossböck; Thomas Rauscher; Peter Winkler; Karin S Kapp; Gerald Langmann
Journal:  Strahlenther Onkol       Date:  2007-10       Impact factor: 3.621

View more
  11 in total

1.  DEGRO practical guidelines for the radiotherapy of non-malignant disorders - Part IV: Symptomatic functional disorders.

Authors:  Gabriele Reinartz; Hans Theodor Eich; Fabian Pohl
Journal:  Strahlenther Onkol       Date:  2014-12-09       Impact factor: 3.621

2.  Dose Distributions and Treatment Margins in Ocular Brachytherapy with 106Ru Eye Plaques.

Authors:  Erik Stöckel; Marion Eichmann; Dirk Flühs; Holger Sommer; Eva Biewald; Norbert Bornfeld; Bernhard Spaan; Wolfgang Sauerwein
Journal:  Ocul Oncol Pathol       Date:  2017-09-16

3.  Monte Carlo Estimation of Absorbed Dose Distributions Obtained from Heterogeneous 106Ru Eye Plaques.

Authors:  Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Wolfgang Sauerwein; Lorenzo Brualla
Journal:  Ocul Oncol Pathol       Date:  2017-02-23

4.  Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric Placement.

Authors:  Lorenzo Brualla; Francisco J Zaragoza; Wolfgang Sauerwein
Journal:  Ocul Oncol Pathol       Date:  2014-05-07

Review 5.  [Lymphoma of the ocular adnexa].

Authors:  V Kakkassery; N Stübiger; I A Adamietz; I Tischoff; A Baraniskin; I M Wunderlich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

6.  Monte Carlo Computation of Dose-Volume Histograms in Structures at Risk of an Eye Irradiated with Heterogeneous Ruthenium-106 Plaques.

Authors:  Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Beate Timmermann; Lorenzo Brualla
Journal:  Ocul Oncol Pathol       Date:  2020-07-20

7.  Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients.

Authors:  M Krengli; L Masini; A M Comoli; E Negri; L Deantonio; A Filomeno; G Gambaro
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

8.  Monte Carlo Simulation of the Treatment of Uveal Melanoma Using Measured Heterogeneous 106Ru Plaques.

Authors:  Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Andrea Wittig; Wolfgang Sauerwein; Lorenzo Brualla
Journal:  Ocul Oncol Pathol       Date:  2018-10-15

Review 9.  Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines.

Authors:  M H Seegenschmiedt; O Micke; R Muecke
Journal:  Br J Radiol       Date:  2015-05-08       Impact factor: 3.039

10.  Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.

Authors:  Somayeh Asadi; Mehdi Vaez-zadeh; S Farhad Masoudi; Faezeh Rahmani; Courtney Knaup; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.